IMCD Marks 30 Years: A Journey of Innovation and Sustainability
IMCD Celebrates 30 Years of Innovation and Growth
IMCD N.V. (“IMCD”), a leading global distribution partner and formulator of specialty chemicals and ingredients, proudly celebrated its 30th anniversary recently. Established in Rotterdam in 1995, IMCD has evolved from a small operation in the Benelux and France to a global powerhouse with over 5,200 employees across more than 60 countries, and supported by 110 offices, 80 laboratories, and 150 warehouses worldwide.
Throughout these three decades, IMCD has redefined the distribution model by fostering genuine partnerships. Collaborating closely with suppliers and clients, the company has co-created innovative and sustainable solutions that stand at the forefront of the industry. Notable achievements throughout this journey include surpassing €1 billion in revenue in 2011 and successfully listing on Euronext Amsterdam in 2014. Moreover, strategic acquisitions such as MF Cachat in the U.S. and Signet in India have strengthened IMCD's position while enhancing its commitment to sustainability initiatives.
Milestones Over the Years
IMCD's history is marked by significant milestones that reflect its impressive growth and adaptability:
Founding and Rebranding
Founded in 1995 by Piet van der Slikke and Hans Kooijmans, IMCD initially operated under modest circumstances. In 2001, the company underwent a rebranding to IMCD, which included the implementation of a unified IT platform to support its international ambitions.
Global Expansion
From 2005 to 2013, IMCD’s global expansion gained momentum across Europe, the Middle East, Africa, Asia-Pacific, and the Americas. By 2011, the company had established a solid footprint in the Asia-Pacific region and surpassed the €1 billion milestone in revenue.
Strategic Acquisitions and Sustainability Initiatives
The period from 2015 to 2019 saw a strengthened presence in North America with the acquisition of MF Cachat, which enhanced IMCD's capabilities in specialty chemicals. Furthermore, the company expanded its network of laboratories and Technical Centres globally.
In 2020, IMCD took a significant step forward in the pharmaceutical sector in Asia-Pacific by acquiring Signet, a leader in excipients. The company's commitment to sustainability intensified during 2022 and beyond, as IMCD joined Together for Sustainability and committed to the Science Based Targets initiative (SBTi), showcasing its dedication to best practices in environmental stewardship.
Leadership Transition and Future Goals
A transformative chapter for IMCD began in 2024 with Valerie Diele-Braun succeeding founder Piet van der Slikke as CEO, followed by Marcus Jordan in 2025. In reflecting on these developments, Marcus Jordan emphasized, "I am deeply honored to lead IMCD into its 30th anniversary, a milestone made possible by the vision of our founder and driven by an entrepreneurial mindset and bold purpose. This success is rooted in our people, our employees, suppliers, and customers, working together in spirit, creativity, and trust. By focusing on creating opportunities and co-developing sustainable solutions, we are poised to write the next chapter of IMCD's story."
About IMCD
Headquartered in Rotterdam, IMCD is a prominent global partner specializing in the distribution and formulation of specialty chemicals and ingredients. The company prides itself on delivering expert solutions and sustainable value throughout the supply chain. With over 5,100 employees, IMCD recorded revenues of EUR 4,728 million recently, and its shares are traded on Euronext Amsterdam under the ticker IMCD. The company's commitment to environmental, social, and governance (ESG) principles is reflected in its inclusion in the Dutch ESG AEX index, recognizing it among the leading companies practicing responsible business.
For more information about IMCD’s initiatives and services, please visit their website.
Media Contact:
Muriel Werlé
Corporate Communications Director
+31 10 290 86 14
mediarelations@imcdgroup.com
Investor Relations Contact:
Tosca Holtland
Head of Investor Relations
+31 10 290 86 53
ir@imcdgroup.com
Frequently Asked Questions
What is IMCD's primary focus in the industry?
IMCD specializes in the distribution and formulation of specialty chemicals and ingredients, aiming to provide innovative solutions across various sectors.
Who founded IMCD and when?
IMCD was founded in 1995 by Piet van der Slikke and Hans Kooijmans in Rotterdam.
What significant milestone did IMCD achieve in 2011?
In 2011, IMCD surpassed €1 billion in revenue, marking a crucial growth point in its history.
How does IMCD demonstrate its commitment to sustainability?
IMCD demonstrates its commitment to sustainability by joining initiatives like Together for Sustainability and the Science Based Targets initiative.
What can we expect from IMCD's leadership in the coming years?
With the new leadership under Marcus Jordan and Valerie Diele-Braun, IMCD is set to focus on innovation, sustainable growth, and expansion into new markets.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.